In the environment of contemporary healthcare, the value of evidence-based medicine cannot be overemphasized. Although randomized controlled trials (RCTs) and systematic reviews are usually the gold standard for clinical evidence, case studies still maintain a crucial position in medical advancement. These comprehensive accounts of a single or small numbers of patients provide distinctive information that

The use of computerized healthcare data has revolutionized storage, access, and application of medical information. Digital Health Records (DHRs) or Electronic Health Records (EHRs) refer to organized sets of patient information in a digital environment that can be transmitted across healthcare institutions. They hold the potential to enhance efficiency, precision, and coordination of patient care.

Over the past decade, medicine has shifted from the traditional “one-size-fits-all” to a more individualized type of care called precision medicine. This new paradigm employs genetic, environmental, and lifestyle information in the design of treatments specifically tailored to the individual patient, instead of using broad clinical guidelines. What is Precision Medicine Precision medicine, also known

Pharmaceutical innovation has remained a pillar of contemporary healthcare, spearheading advances that save lives, enhance quality care, and increase longevity. From innovative oncology medications to new-generation biologics and personalized medicine, the pharma industry continues to revolutionize treatment paradigms. But with this enormous ability to innovate comes an equally relevant mandate: making progress consistent with ethical

Over the past few years, the healthcare sector has seen a paradigm shift in how patients are linked with doctors. Telemedicine, one of the most potent innovations bringing that shift about, is a digital corridor connecting patients with healthcare professionals that takes care well beyond the confines of the traditional hospital. An idea that seemed

Imagine this: you’ve been taking a medicine for months, trusting that it’s safe, only to find out later that it increases your risk of stroke or heart problems. Shocking, right? When a drug is approved by agencies like the FDA (U.S. Food and Drug Administration) or the EMA (European Medicines Agency), both doctors and patients

Open Access publishing has become a game-changing solution that makes scientific information openly accessible to researchers, healthcare workers, policymakers, and the public. The need for open dissemination of research has never been more imperative as the world’s healthcare continues to move at a rapid pace. Costly models of subscription-based publishing restrict access to precious information

The drug industry is witnessing a colossal change. With the advent of Pharma 5.0, a new revolution is underway—one where artificial intelligence (AI) is driving drug discovery quicker, smarter, and more accurate. From interpreting massive biological data to forecasting clinical trial success, AI is transforming our approach to medicine.   What is Pharma 5.0?